ACTIVE

UNIVERSAL PHARMA

Financial year 2025 · closed on 31/12/2025
Net result
2 M €
+9.7% YoY
Revenue
51,5 M €
+5.9% YoY
Equity
23,1 M €
+8.4% YoY
Workforce
134,5 ETP
-0.8% YoY

What does UNIVERSAL PHARMA do?

UNIVERSAL PHARMA is a Public limited company incorporated in 1992. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Frameries. It employs on average 134,5 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0447.382.113
Incorporation
12/05/1992
Legal form
Public limited company
Registered office
Rue Montavaux 155
7080 Frameries · WallonieSee on map
Contributed capital
1 500 000,00 €
Latest accounts
31/12/2025
Average workforce
134,5 ETP
Joint committees (1)
  • 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 20 financial years

20252024202320222021202020192018201720162015201420132012201120102009200820072006
Income statement
Revenue51,5 M €48,7 M €41,7 M €39,7 M €37,3 M €37,1 M €35,3 M €34,3 M €35,5 M €35,3 M €31,8 M €31,6 M €27,7 M €25,9 M €26,3 M €23,9 M €22,2 M €21,3 M €20 M €19 M €
EBITDA3,1 M €2,7 M €2 M €2,5 M €3 M €1,7 M €1,3 M €1,6 M €1,4 M €1,4 M €627 k €1,2 M €911,9 k €391,4 k €637,3 k €486,6 k €419 k €241,9 k €676,3 k €861,1 k €
Operating result2,3 M €2 M €1,4 M €2,1 M €2,5 M €1,2 M €767,1 k €1,1 M €930,1 k €898,8 k €122,5 k €664,9 k €400,6 k €-69,6 k €176,5 k €39,2 k €-35,5 k €-175,5 k €290,9 k €488,3 k €
Net result2 M €1,9 M €1,4 M €1,9 M €2,2 M €2,2 M €970,3 k €1,2 M €1 M €1,2 M €1,1 M €854,7 k €691 k €122,7 k €506,6 k €415,4 k €309 k €271,3 k €487,5 k €583,9 k €
Balance sheet
Equity23,1 M €21,3 M €20,2 M €19,8 M €17,8 M €15,6 M €13,4 M €12,4 M €11,3 M €10,2 M €9 M €7,9 M €7 M €6,3 M €6,2 M €5,7 M €5,3 M €5 M €4,7 M €4,2 M €
Total assets31,5 M €29 M €29 M €26,6 M €23,7 M €22,9 M €21,6 M €20,1 M €19,2 M €18,6 M €17 M €16,5 M €16,7 M €15,1 M €16,1 M €14,7 M €12,4 M €10,9 M €11,2 M €11,2 M €
Cash5,2 M €4 M €4,6 M €3,3 M €1,9 M €2,6 M €3,1 M €2,8 M €1,7 M €1,5 M €875,5 k €592,6 k €1,2 M €676,8 k €1,1 M €1,2 M €971,5 k €960,1 k €684,9 k €428,3 k €
Debts8,2 M €7,3 M €8,4 M €6,8 M €5,6 M €7,1 M €7,9 M €7,5 M €7,7 M €8,3 M €7,9 M €8,5 M €9,7 M €8,7 M €9,9 M €9 M €7 M €5,9 M €6,5 M €6,9 M €
Other
Workforce134,5 ETP135,6 ETP132,1 ETP121,0 ETP116,0 ETP122,0 ETP118,0 ETP109,0 ETP107,2 ETP107,9 ETP105,3 ETP101,1 ETP92,4 ETP83,9 ETP44,2 ETP40,9 ETP39,2 ETP36,6 ETP37,2 ETP46,1 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 10 M€ and 25 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 17 ended

Active mandates

FINPHARMA SA LU23789688

Director · since 30 juin 2024 · until 30 juin 2030

Represented by PHILIPPE BOULANGER

Active
GESTIPHARMA

Managing director · since 30 juin 2024 · until 30 juin 2030 · 0425.530.684

Represented by PIERRE-PASCAL HECQ

Active

Ended mandates

FARMIMMO

Director · since 05 octobre 2020 · until 14 septembre 2022 · 0429.198.175

Represented by PIERRE-PASCAL HECQ

Ended
FARMIMMO

Director · since 05 octobre 2020 · until 12 juin 2026 · 0429.198.175

Ended
FINPHARMA SA LU23789688

Director · since 05 octobre 2020 · until 12 juin 2026

Represented by PHILIPPE BOULANGER

Ended
GESTIPHARMA

Managing director · since 05 octobre 2020 · until 12 juin 2026 · 0425.530.684

Represented by PIERRE-PASCAL HECQ

Ended
At this address

Other companies at this address

CompanyCBE no.
ASSCOTActive
0447.778.625
0478.169.913
BEPHARActive
0450.260.538
EVRASActive
0417.723.174
FARMIMMOActive
0429.198.175
FELIX PHARMAActive
0477.939.091
0443.155.782
0403.358.761
0466.956.812
0435.700.442
0403.082.213
OBIPHARActive
0878.100.418
0882.318.631
0423.162.203
0867.368.654
0842.900.009
0479.179.208
0419.745.130
0447.088.737
0439.400.397
Annual accounts

Full financial information

202520242023202220212020
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date07/07/202603/07/202528/08/202426/07/202318/08/202217/08/2021
General meeting30/06/202630/06/202530/06/202428/06/202330/06/202230/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

21 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202530/06/202607/07/2026FrenchPDF
Full model31/12/202430/06/202503/07/2025FrenchPDF
Full model31/12/202330/06/202428/08/2024FrenchPDF
Full model31/12/202228/06/202326/07/2023FrenchPDF
Full model31/12/202130/06/202218/08/2022FrenchPDF
Full modelCorrection31/12/202030/06/202117/08/2021FrenchPDF
Full model31/12/202030/06/202109/08/2021FrenchPDF
Full model31/12/201926/06/202012/08/2020FrenchPDF
Full model31/12/201830/06/201908/08/2019FrenchPDF
Full model31/12/201708/06/201802/08/2018FrenchPDF
Full model31/12/201630/06/201717/07/2017FrenchPDF
Full model31/12/201530/06/201626/07/2016FrenchPDF
Full model31/12/201430/06/201529/07/2015FrenchPDF
Full model31/12/201330/06/201428/07/2014FrenchPDF
Full model31/12/201230/06/201312/07/2013FrenchPDF
Full model31/12/201130/06/201209/07/2012FrenchPDF
Full model31/12/201030/06/201129/07/2011FrenchPDF
Full model31/12/200930/06/201026/08/2010FrenchPDF
Full model31/12/200825/06/200905/08/2009FrenchPDF
Full model31/12/200713/06/200822/08/2008FrenchPDF
Full model31/12/200608/06/200702/08/2007FrenchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 10 M€ and 25 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 17 ended

Active mandates

FINPHARMA SA LU23789688

Director · since 30 juin 2024 · until 30 juin 2030

Represented by PHILIPPE BOULANGER

Active
GESTIPHARMA

Managing director · since 30 juin 2024 · until 30 juin 2030 · 0425.530.684

Represented by PIERRE-PASCAL HECQ

Active

Ended mandates

FARMIMMO

Director · since 05 octobre 2020 · until 14 septembre 2022 · 0429.198.175

Represented by PIERRE-PASCAL HECQ

Ended
FARMIMMO

Director · since 05 octobre 2020 · until 12 juin 2026 · 0429.198.175

Ended
FINPHARMA SA LU23789688

Director · since 05 octobre 2020 · until 12 juin 2026

Represented by PHILIPPE BOULANGER

Ended
GESTIPHARMA

Managing director · since 05 octobre 2020 · until 12 juin 2026 · 0425.530.684

Represented by PIERRE-PASCAL HECQ

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates04/12/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates29/12/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Other20/10/2022
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates22/12/2021
    DEMISSIONS, NOMINATIONS - DIVERS
    PDF
  • Mandates06/11/2020
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates03/08/2016
    DEMISSIONS, NOMINATIONS
    PDF
  • Other27/12/2013
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Restructuring23/07/2012
    CAPITAL, ACTIONS - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 20252 M €
  2. 2024
    Annual accounts 20241,9 M €
  3. 2023
    Annual accounts 20231,4 M €
  4. 2022
    Annual accounts 20221,9 M €
  5. 2021
    Annual accounts 20212,2 M €
  6. 2020
    Annual accounts 20202,2 M €
  7. 2019
    Annual accounts 2019970,3 k €
  8. 2018
    Annual accounts 20181,2 M €
  9. 2017
    Annual accounts 20171 M €
  10. 2016
    Annual accounts 20161,2 M €
  11. 2015
    Annual accounts 20151,1 M €
  12. 2014
    Annual accounts 2014854,7 k €
  13. 2013
    Annual accounts 2013691 k €
  14. 2012
    Annual accounts 2012122,7 k €
  15. 2011
    Annual accounts 2011506,6 k €
  16. 2010
    Annual accounts 2010415,4 k €
  17. 2009
    Annual accounts 2009309 k €
  18. 2008
    Annual accounts 2008271,3 k €
  19. 2007
    Annual accounts 2007487,5 k €
  20. 2006
    Annual accounts 2006583,9 k €
  21. 12/05/1992
    IncorporationPublic limited company